Rheumatic diseases in pregnancy;Rheumatische erkrankungen in der schwangerschaft

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 46, 2008, Pages 2410-2414

  Märker Hermann, Elisabeth ^a   Bauer, H ^a   Gromnica Ihle, E ^b  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

^b Rheuma für Die Praxis   (Germany)

Author keywords

Pharmacotherapy; Pregnancy; Rheumatic diseases

Indexed keywords

ANKYLOSING SPONDYLITIS; ANTIPHOSPHOLIPID SYNDROME; PREGNANCY; PSORIATIC ARTHRITIS; REVIEW; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; DRUG CONTRAINDICATION; FEMALE; HUMAN; IMMUNOLOGY; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENT;

ANTIPHOSPHOLIPID SYNDROME; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RHEUMATIC DISEASES; SPONDYLITIS, ANKYLOSING;

EID: 55749087144     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1100933     Document Type: Review

References (18)

1. Bertsias G, Ioannidis JP, Boletis J et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008; 67: 195-205
2. Bowden AP, Barrett JH, Fallow W, Silman AJ. Women with inflammatory polyarthritis have babies of lower birth weight. J Rheumatol 2001; 28: 355-359
3. Buyon JP, Yaron M, Lockshine MD. First International Conference on Rheumatic Diseases in Pregnancy. Arthritis Rheum 1993; 36: 59-64
4. Costedoat-Chalumeau N, Amoura Z, Huong DL et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature. Autoimmun Rev 2005; 4: 111-115
5. Gromnica-Ihle E, Østensen M. Schwangerschaft bei rheumatoider Arthritis oder Spondyloarthritiden. Z Rheumatol 2006; 65: 209-16
6. Hench PS. The ameliorating effect of pregnancy on chronic atrophic (infectious rheumatoid) arthritis, fibrosis, and intermittent hydarthrosis. Mayo Clin Proc 1938; 13: 161-167
7. Katz JA, Antoni C, Keenan GF et al. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-2392
8. Miyakis S, Lockshin MD, Atsumi T et al. International consensus statement on an update of the classification criteria for definite aniphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306
9. Norgard B, Czeizel AE, Rockenbauer M et al. Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001; 15: 483-486
10. Østensen M, Romberg O, Husby G. Ankylosing spondylitis and motherhood. Arthritis Rheum 1982; 25: 140-143
11. Østensen M, Husby G. A prospective clinical study of the effect of pregnancy on rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 1983; 26: 1155-1159
12. Østensen M, Østensen H. Ankylosing spondylitis - the female aspect. J Rheumatol 1998; 25: 120-124
13. Østensen M, Förger F, Nelson JL et al. Pregnancy in patients with rheumatic disease: anti-inflammatory cytokines increase in pregnancy and decrease post partum. Ann Rheum Dis 2005; 64: 839-844
14. Østensen M, Lockshin M, Doria A et al. Update on safety during pregnancy of biological agents and some immunosuppressive anti-rheumatic drugs. Rheumatology (Oxford) 2008; 47 Suppl 3: iii28-31
15. Ruiz-Irastorza G, Khamashta MA. Systemischer Lupus erythematodes und Antiphospholipidsyndrom in der Schwangerschaft. Z Rheumatol 2006; 65: 192-195
16. Schaefer C, Weber-Schöndorfer C. Medikamentöse Therapie in der Schwangerschaft. Dtsch Ärzteblatt 2005; 102: A2480-A2489
17. Silman AJ. Contraceptives, pregnancy, and RA. Ann Rheum Dis 2002; 61: 383-385
18. Skomsvoll JF, Østensen M, Baste V, Irgens LM. Number of births, interpregnancy interval, and subsequent pregnancy rate after a diagnosis of inflammatory rheumatic disease in Norwegian women. J Rheumatol 2001; 28: 2310-2314